Prognostic impact of shift to low visceral fat mass after neoadjuvant chemotherapy in patients with esophageal cancer
This study suggests that prevention of the shift to low visceral fat throughout the neoadjuvant chemotherapy process should improve patient outcomes.
Authors
- Masahito Shimizu (ORCID: https://orcid.org/0000-0002-1151-2058)
- Tetsuya Abe (ORCID: https://orcid.org/0000-0002-6976-9753)
- Kei Muro
- Yoshitaka Inaba (ORCID: https://orcid.org/0000-0002-0850-6327)
- Sachiyo Onishi (ORCID: https://orcid.org/0000-0001-8633-1019)
- Keisaku Yamada
- Tsutomu Tanaka (ORCID: https://orcid.org/0000-0002-9381-8738)
- Yasumasa Niwa
- Masahiro Tajika
Institutions
- Aichi Cancer Center (JP)
- Gifu University (JP)
Publication Details
- Journal
- Cancer Reports
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1002/cnr2.2084
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00